UPDATE: Morgan Stanley Double Downgrades Centessa Pharmaceuticals (CNTA) to Underweight
Tweet Send to a Friend
(Updated - August 12, 2022 5:20 AM EDT)
Morgan Stanley analyst Matthew Harrison downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
